Table 3. N-Glycan profiling by DNA sequencer-assisted/fluorophore-assisted capillary electrophoresis.

	Means±SD
Variable	Control (n=128)	Atrophic Gastritis (n=108)	GC (n=138)	F	P
Age, ya	50.10±5.95	52.11±6.29	51.01±6.01	0.27	0.766
Peak 1a	6.96±1.67	7.64±2.02	8.20±2.75	10.09	<0.001
Peak 2a	1.09±0.34	1.20±0.38	1.31±0.49	3.12	0.045
Peak 3a	6.28±1.63	6.47±1.38	5.76±1.28	10.48	<0.001
Peak 4a	5.76±0.93	5.61±0.81	5.75±0.82	1.12	0.327
Peak 5a	40.02±3.75	39.60±3.76	42.16±4.33	14.94	<0.001
Peak 6a	21.40±2.61	20.51±2.85	16.99±2.98	88.36	<0.001
Peak 7a	5.87±1.41	6.02±1.71	5.21±1.21	11.15	<0.001
Peak 8a	7.94±1.58	7.59±2.24	7.46±1.82	2.24	0.108
Peak 9a	2.33±0.92	2.59±1.55	4.00±1.77	48.12	<0.001
sumfucab	47.37±4.40	47.47±5.30	43.21±5.94	27.01	<0.001

Abbreviations: GC, gastric carcinoma; SD, standard deviation.

^a analyses of variance

^b Sumfuc represents the total abundance of α-1,6-fucosylated structures (the sum of peaks 1, 2, 3, 4, 6, and 7).